Amedeo Smart

Free Medical Literature Service

 

Amedeo

Stem Cell Research
  Free Subscription

Articles published in
Blood
    September 2024
  1. SAFINA K, van Galen P
    New frameworks for hematopoiesis derived from single-cell genomics.
    Blood. 2024;144:1039-1047.
    >> Share

    August 2024
  2. CULL AH, Kent DG, Warren AJ
    Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disorders.
    Blood. 2024;144:931-939.
    >> Share

  3. SCHYRR F, Alonso-Calleja A, Vijaykumar A, Sordet-Dessimoz J, et al
    Inducible CXCL12/CXCR4-dependent extramedullary hematopoietic niches in the adrenal gland.
    Blood. 2024;144:964-976.
    >> Share

  4. APOSTOLOVA P
    GVHD: bile duct stem cells under attack.
    Blood. 2024;144:805-807.
    >> Share

  5. HAMAD N
    How I approach intersectionality in hematopoietic stem cell transplantation.
    Blood. 2024 Aug 16:blood.2023020778. doi: 10.1182/blood.2023020778.
    >> Share

  6. LYU J, Xu J
    Context matters: role of ATF4 in hematopoiesis.
    Blood. 2024;144:684-686.
    >> Share

  7. ZHENG Z, Yang S, Gou F, Tang C, et al
    The ATF4-RPS19BP1 axis modulates ribosome biogenesis to promote erythropoiesis.
    Blood. 2024;144:742-756.
    >> Share

  8. WANG B, Shi D, Yang S, Lian Y, et al
    Mitochondrial tRNA pseudouridylation governs erythropoiesis.
    Blood. 2024;144:657-671.
    >> Share

    July 2024

  9. Dimitriou M, Mortera-Blanco T, Tobiasson M, et al. Identification and surveillance of rare relapse-initiating stem cells during complete remission after transplantation. Blood. 2024;143(11):953-966.
    Blood. 2024;144:464.
    >> Share

  10. MACLEAN AL, Rudolph KL
    Hematopoietic stem cell aging by the niche.
    Blood. 2024;144:347-348.
    >> Share

  11. LOCATELLI F, Kang HJ, Bruno B, Gandemer V, et al
    Ruxolitinib for pediatric patients with treatment-naive and steroid-refractory acute graft-versus-host disease (REACH4).
    Blood. 2024 Jul 24:blood.2023022565. doi: 10.1182/blood.2023022565.
    >> Share

  12. KEAN LS, Burns LJ, Kou TD, Kapikian R, et al
    Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
    Blood. 2024 Jul 19:blood.2023023660. doi: 10.1182/blood.2023023660.
    >> Share

  13. PIDALA JA, Gooley TA, Luznik L, Blazar BR, et al
    Chronic graft-versus-host disease: Unresolved complication or ancient history?
    Blood. 2024 Jul 15:blood.2023022735. doi: 10.1182/blood.2023022735.
    >> Share

  14. LOEFFLER D
    CDK6: HSC fate and cell cycle nexus?
    Blood. 2024;144:126-128.
    >> Share

  15. LUM SH, Eikema DJ, Piepenbroek B, Wynn R, et al
    Outcome of Hematopoietic Stem Cell Transplantation in 813 Pediatric Patients with Fanconi Anemia.
    Blood. 2024 Jul 5:blood.2023022751. doi: 10.1182/blood.2023022751.
    >> Share

    June 2024
  16. RADPOUR R, Simillion C, Wang B, Abbas HA, et al
    IL-9 Secreted by Leukemia Stem Cells Induces Th1-Skewed CD4+ T-Cells, which Promote Their Expansion.
    Blood. 2024 Jun 28:blood.2024024000. doi: 10.1182/blood.2024024000.
    >> Share

  17. GUERRERO P, Bono C, Soben M, Guiu A, et al
    GM-CSF receptor expression determines opposing innate memory phenotypes at different stages of myelopoiesis.
    Blood. 2024;143:2763-2777.
    >> Share

  18. HASEGAWA Y, Hashimoto D, Zhang Z, Miyajima T, et al
    GVHD targets organoid-forming bile duct stem cells via a TGF-beta-dependent manner.
    Blood. 2024 Jun 21:blood.2023023060. doi: 10.1182/blood.2023023060.
    >> Share


  19. Houde CA, Khan A, Jacobus SJ, et al. Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus Rvd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (Pts) with newly
    Blood. 2024;143:2676.
    >> Share

  20. CONSTANTINESCU SN, Vainchenker W
    DNMT3A gates IFN-induced MPN HSC exhaustion.
    Blood. 2024;143:2445-2446.
    >> Share

  21. USART M, Stetka J, Luque Paz D, Hansen N, et al
    Loss of Dnmt3a increases self-renewal and resistance to pegIFN-alpha in JAK2-V617F-positive myeloproliferative neoplasms.
    Blood. 2024;143:2490-2503.
    >> Share

    May 2024
  22. LIU G, Kim J, Nguyen N, Zhou L, et al
    Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape modulation.
    Blood. 2024;143:2300-2313.
    >> Share

  23. JOHNSON CS, Williams MJ, Sham K, Belluschi S, et al
    Adaptation to ex vivo culture reduces human hematopoietic stem cell activity independently of cell cycle.
    Blood. 2024 May 28:blood.2023021426. doi: 10.1182/blood.2023021426.
    >> Share

  24. MANZ MG, Caiado F
    IL-1 in Aging and Pathologies of Hematopoietic Stem Cells.
    Blood. 2024 May 23:blood.2023023105. doi: 10.1182/blood.2023023105.
    >> Share

  25. ALLISON RL, Welby E, Ehlers V, Burand A, et al
    Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.
    Blood. 2024;143:2037-2052.
    >> Share

  26. MORALES-HERNANDEZ A
    Patrolling progenitors: a first responder team.
    Blood. 2024;143:1883-1884.
    >> Share

  27. QUARANTA P, Basso-Ricci L, Jofra Hernandez R, Pacini G, et al
    Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis.
    Blood. 2024;143:1937-1952.
    >> Share


  28. Gagelmann N, Badbaran A, Salit RB, et al. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood. 2023;141(23):2901-2911.
    Blood. 2024;143:1879.
    >> Share

    April 2024
  29. MAYER IM, Doma E, Klampfl T, Prchal-Murphy M, et al
    Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells.
    Blood. 2024 Apr 29:blood.2023021985. doi: 10.1182/blood.2023021985.
    >> Share

  30. KRAKOW EF, Brault M, Summers C, Cunningham TM, et al
    HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
    Blood. 2024 Apr 29:blood.2024024105. doi: 10.1182/blood.2024024105.
    >> Share


  31. Matsuoka S, Facchini R, Luis TC, et al. Loss of endothelial membrane KIT ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells. Blood. 2023;142(19):1622-1632.
    Blood. 2024;143:1677.
    >> Share

  32. MAPPERLEY C, Kranc KR
    HOXA9 and beta-catenin safeguard HSC integrity.
    Blood. 2024;143:1554-1556.
    >> Share

  33. YOUNG KA, Telpoukhovskaia MA, Hofmann J, Mistry JJ, et al
    Variation in Mesenchymal KITL/SCF and IGF1 Expression at Middle Age Underlies Steady-State Hematopoietic Stem Cell Aging.
    Blood. 2024 Apr 10:blood.2024024275. doi: 10.1182/blood.2024024275.
    >> Share

  34. HASSAN N, Yi H, Malik B, Gaspard-Boulinc LC, et al
    Loss of stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML.
    Blood. 2024 Apr 5:blood.2024024072. doi: 10.1182/blood.2024024072.
    >> Share

  35. HOFMANN J, Kokkaliaris K
    Bone marrow niches for hematopoietic stem cells: Lifespan dynamics and adaptation to acute stress.
    Blood. 2024 Apr 5:blood.2023023788. doi: 10.1182/blood.2023023788.
    >> Share

  36. DEZERN AE
    A way to "mimic" the pathophysiology of acquired SAA.
    Blood. 2024;143:1318-1320.
    >> Share

    March 2024
  37. PISZCZATOWSKI RT, Buelow H, Steidl U
    Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis.
    Blood. 2024 Mar 22:blood.2023022736. doi: 10.1182/blood.2023022736.
    >> Share

  38. WILKINSON AC
    Take the MYC to expand blood stem cells.
    Blood. 2024;143:838-840.
    >> Share

  39. SACCO A, Roccaro AM
    Waking up exhausted BCMA-specific T cells in myeloma.
    Blood. 2024;143:840-841.
    >> Share


  40. Colom Diaz PA, Mistry JJ, Trowbridge JJ. Hematopoietic stem cell aging and leukemia transformation. Blood. 2023;142(6):533-542.
    Blood. 2024;143:939.
    >> Share

    February 2024
  41. MURTADHA M, Park M, Zhu Y, Caserta E, et al
    CD38-directed, single-chain T cell-engager targets leukemia stem cells through IFNgamma-induced CD38 expression.
    Blood. 2024 Feb 26:blood.2023021570. doi: 10.1182/blood.2023021570.
    >> Share

  42. FISKUS W, Piel J, Collins MP, Hentemann M, et al
    BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor.
    Blood. 2024 Feb 16:blood.2023022832. doi: 10.1182/blood.2023022832.
    >> Share

  43. KIM OV, Litvinov RI, Gagne AL, French DL, et al
    Megakaryocyte-induced contraction of plasma clots: cellular mechanisms and structural mechanobiology.
    Blood. 2024;143:548-560.
    >> Share

    January 2024
  44. TAKAHASHI S, Minnie SA, Ensbey KS, Schmidt CR, et al
    Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
    Blood. 2024 Jan 31:blood.2023022000. doi: 10.1182/blood.2023022000.
    >> Share

  45. BEN HAMZA A, Welters C, Stadler S, Bruggemann M, et al
    Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Blood. 2024 Jan 26:blood.2023023142. doi: 10.1182/blood.2023023142.
    >> Share

  46. GU H, Chen C, Hou ZS, He XD, et al
    PI3Kgamma maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway.
    Blood. 2024 Jan 25:blood.2023022202. doi: 10.1182/blood.2023022202.
    >> Share

  47. UEHATA T, Yamada S, Ori D, Vandenbon A, et al
    Regulation of lymphoid-myeloid lineage bias through regnase-1/3-mediated control of Nfkbiz.
    Blood. 2024;143:243-257.
    >> Share

  48. KHANDELWAL P, Langenberg L, Luebbering N, Lake K, et al
    A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults.
    Blood. 2024 Jan 16:blood.2023022865. doi: 10.1182/blood.2023022865.
    >> Share

  49. LYNCH J, Troadec E, Fung TK, Gladysz K, et al
    Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient beta-catenin/Hoxa9/Prmt1 axis.
    Blood. 2024 Jan 11:blood.2023022082. doi: 10.1182/blood.2023022082.
    >> Share

  50. CHAGRAOUI J, Girard S, Mallinger L, Mayotte N, et al
    KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment.
    Blood. 2024 Jan 11:blood.2023021342. doi: 10.1182/blood.2023021342.
    >> Share

  51. KHANNA R, Gandhi MK
    EBV-infected hematopoietic stem cells drive CAEBV.
    Blood. 2024;143:2-4.
    >> Share

    December 2023
  52. SARACHAKOV A, Varlamova A, Svekolkin V, Polyakova M, et al
    Spatial mapping of human hematopoiesis at single-cell resolution reveals aging-associated topographic remodeling.
    Blood. 2023;142:2282-2295.
    >> Share

  53. DIMITRIOU M, Mortera-Blanco T, Tobiasson M, Mazzi S, et al
    Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation.
    Blood. 2023 Dec 14:blood.2023022851. doi: 10.1182/blood.2023022851.
    >> Share

  54. ADAMS RC, Carter-Cusack D Mr, Llanes GT, Hunter CR, et al
    CSF1R inhibition promotes neuroinflammation and behavioural deficits during graft-versus-host disease in mice.
    Blood. 2023 Dec 4:blood.2023022040. doi: 10.1182/blood.2023022040.
    >> Share

    November 2023
  55. XIE SZ
    Sphingolipids and HSC fitness: enigma no more.
    Blood. 2023;142:1674-1676.
    >> Share

  56. BUENO C, Torres-Ruiz R, Velasco-Hernandez T, Molina O, et al
    A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
    Blood. 2023;142:1752-1756.
    >> Share

  57. JODELE S, Dandoy CE, Aguayo-Hiraldo P, Lane A, et al
    Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA.
    Blood. 2023 Nov 9:blood.2023022526. doi: 10.1182/blood.2023022526.
    >> Share

  58. ZHANG S, Pinho S
    Untangling the role of KIT ligand in HSC regulation.
    Blood. 2023;142:1581-1582.
    >> Share

    October 2023
  59. BAE J, Kitayama S, Herbert Z, Daheron L, et al
    Differentiation of BCMA-specific induced pluripotent stem cells into CD8alphabeta+ T cells targeting multiple myeloma.
    Blood. 2023 Oct 27:blood.2023020528. doi: 10.1182/blood.2023020528.
    >> Share

  60. SUBRAMANIAN S, Thoms JAI, Huang Y, Cornejo-Paramo P, et al
    Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
    Blood. 2023;142:1448-1462.
    >> Share

  61. MASETTI R, Leardini D, Muratore E, Fabbrini M, et al
    Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children.
    Blood. 2023;142:1387-1398.
    >> Share

  62. WANG J, Su M, Wei N, Yan H, et al
    Chronic Active Epstein-Barr Virus Disease Originates from Infected Hematopoietic Stem Cells.
    Blood. 2023 Oct 12:blood.2023021074. doi: 10.1182/blood.2023021074.
    >> Share

    September 2023
  63. TANG B, Wang X, He H, Chen R, et al
    Aging-disturbed FUS Phase Transition Impairs Hematopoietic Stem Cell by Altering Chromatin Structure.
    Blood. 2023 Sep 25:blood.2023020539. doi: 10.1182/blood.2023020539.
    >> Share

  64. CARTER BZ, Mak PY, Muftuoglu M, Tao W, et al
    Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
    Blood. 2023;142:1056-1070.
    >> Share

  65. HURWITZ SN, Jung SK, Kobulsky DR, Fazelinia H, et al
    Neutral sphingomyelinase blockade enhances hematopoietic stem cell fitness through an integrated stress response.
    Blood. 2023 Sep 12:blood.2023022147. doi: 10.1182/blood.2023022147.
    >> Share

    August 2023
  66. VAVASSORI V, Ferrari S, Beretta S, Asperti C, et al
    Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.
    Blood. 2023;142:812-826.
    >> Share

  67. RHEE C, Scadden EW, Wong LP, Schiroli G, et al
    Limited plasticity of monocyte fate and function associated with epigenetic scripting at the level of progenitors.
    Blood. 2023;142:658-674.
    >> Share

  68. WU L, Lin Q, Chatla S, Amarachintha SP, et al
    LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging.
    Blood. 2023 Aug 15:blood.2022018212. doi: 10.1182/blood.2022018212.
    >> Share

  69. SEZAKI M, Huang G
    Food for thought (and CML survival).
    Blood. 2023;142:502-504.
    >> Share

  70. CRISPINO JD
    Introduction to a review series on hematopoietic stem cells.
    Blood. 2023;142:497.
    >> Share

  71. MATSUOKA S, Facchini R, Luis TC, Carrelha J, et al
    Loss of endothelial membrane KIT Ligand affects systemic KIT ligand levels but not bone marrow hematopoietic stem cells.
    Blood. 2023 Aug 10:blood.2022019018. doi: 10.1182/blood.2022019018.
    >> Share

  72. FENG J, Hsu PF, Esteva E, Labella R, et al
    Haplodeficiency of the 9p21 tumor suppressor locus causes myeloid disorders driven by the bone marrow microenvironment.
    Blood. 2023;142:460-476.
    >> Share

  73. GOTZE KS
    Flipping the switch in the stem cell niche.
    Blood. 2023;142:404-406.
    >> Share

    July 2023
  74. LABROSSE R, Chu J, Armant M, Everett JK, et al
    Outcomes of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome.
    Blood. 2023 Jul 21:blood.2022019117. doi: 10.1182/blood.2022019117.
    >> Share

  75. VELOSO A, Cools J
    Targeting STAT5B in T-cell acute lymphoblastic leukemia.
    Blood. 2023;142:215-217.
    >> Share

  76. BAMEZAI S, Pulikkottil AJ, Yadav T, Vegi NM, et al
    A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML.
    Blood. 2023;142:90-105.
    >> Share

  77. RADTKE S, Enstrom M, Pande D, Duke ER, et al
    Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation.
    Blood. 2023;142:33-43.
    >> Share

    June 2023
  78. CALVANESE V, Mikkola H
    The genesis of human hematopoietic stem cells.
    Blood. 2023 Jun 20:blood.2022017934. doi: 10.1182/blood.2022017934.
    >> Share

  79. MERRILL MH, Dahi PB, Redd RA, McDonough M, et al
    A Phase 2 Study of pembrolizumab after Autologous Stem Cell Transplantation in Patients with T-Cell non-Hodgkin Lymphoma.
    Blood. 2023 Jun 15:blood.2023020244. doi: 10.1182/blood.2023020244.
    >> Share

    May 2023
  80. MUNZ CM, Dressel N, Chen M, Grinenko T, et al
    Regeneration after blood loss and acute inflammation proceeds without contribution of primitive HSCs.
    Blood. 2023;141:2483-2492.
    >> Share

  81. QIU S, Sheth VS, Yan C, Liu J, et al
    Metabolic Adaptation to Tyrosine Kinase Inhibition in Leukemia Stem Cells.
    Blood. 2023 May 16:blood.2022018196. doi: 10.1182/blood.2022018196.
    >> Share


  82. Albert MH, Sirait T, Eikema D-J, et al. Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood. 2022;140(14):1635-1649.
    Blood. 2023;141:2284.
    >> Share

    April 2023
  83. LI C, Georgakopoulou A, Newby GA, Chen PJ, et al
    In vivo HSC prime editing rescues sickle cell disease in a mouse model.
    Blood. 2023;141:2085-2099.
    >> Share

  84. GONDA TJ
    MYB deficiency leads to myeloid neoplasia too.
    Blood. 2023;141:1786-1787.
    >> Share

  85. PIETRAS EM
    Young bugs rejuvenate old blood.
    Blood. 2023;141:1650-1652.
    >> Share

  86. ANJOS-AFONSO F, Bonnet D
    Human CD34+ hematopoietic stem cell hierarchy: how far are we with its delineation at the most primitive level?
    Blood. 2023 Apr 5:blood.2022018071. doi: 10.1182/blood.2022018071.
    >> Share

  87. DOLINSKA M, Cai H, Mansson A, Shen J, et al
    Characterization of Bone Marrow Niche in Chronic Myeloid Leukemia Patients Identifies CXCL14 as a New Therapeutic Option.
    Blood. 2023 Apr 5:blood.2022016896. doi: 10.1182/blood.2022016896.
    >> Share

    March 2023
  88. TREMBLAY CS, Saw J, Boyle JA, Haigh K, et al
    STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia.
    Blood. 2023 Mar 29:blood.2022016322. doi: 10.1182/blood.2022016322.
    >> Share

  89. ZHAO HG, Deininger MW
    ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS.
    Blood. 2023 Mar 22:blood.2022017152. doi: 10.1182/blood.2022017152.
    >> Share

  90. GAGELMANN N, Badbaran A, Salit RB, Schroeder T, et al
    Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
    Blood. 2023 Mar 20:blood.2023019630. doi: 10.1182/blood.2023019630.
    >> Share

  91. SCHNEGG-KAUFMANN AS, Thoms JAI, Bhuyan GS, Hampton HR, et al
    Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy.
    Blood. 2023;141:1316-1321.
    >> Share

  92. NGAI LL, Hanekamp D, Janssen F, Carbaat-Ham J, et al
    Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial.
    Blood. 2023 Mar 10:blood.2022019160. doi: 10.1182/blood.2022019160.
    >> Share


  93. Burgos da Silva M, Ponce DM, Dai A, et al. Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease. Blood. 2022;140(22):2385-2397.
    Blood. 2023;141:1234.
    >> Share

  94. KOSHY AG, Kim HT, Liegel J, Arnason JE, et al
    Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease.
    Blood. 2023 Mar 2:blood.2022019107. doi: 10.1182/blood.2022019107.
    >> Share

    February 2023

  95. Lopez de Lapuente Portilla A, Ekdahl L, Cafaro C, et al. Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+ cell levels. Blood. 2022;139(11):1659-1669.
    Blood. 2023;141:962.
    >> Share

  96. CICHOCKI F, van der Stegen SJC, Miller JS
    Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies.
    Blood. 2023;141:846-855.
    >> Share

  97. COLOM DIAZ PA, Mistry JJ, Trowbridge JJ
    Hematopoietic Stem Cell Aging and Leukemia Transformation.
    Blood. 2023 Feb 17:blood.2022017933. doi: 10.1182/blood.2022017933.
    >> Share

  98. LINDER MI, Mizoguchi Y, Hesse S, Csaba G, et al
    Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes.
    Blood. 2023;141:645-658.
    >> Share

  99. JASSINSKAJA M, Gonka M, Kent D
    Resolving the hematopoietic stem cell state by linking functional and molecular assays.
    Blood. 2023 Feb 3:blood.2022017864. doi: 10.1182/blood.2022017864.
    >> Share

    January 2023
  100. HAMMOND CA, Wu SW, Wang F, MacAldaz ME, et al
    Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells.
    Blood. 2023 Jan 18:blood.2022017174. doi: 10.1182/blood.2022017174.
    >> Share

  101. ZENG X, Li X, Li X, Wei C, et al
    Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation.
    Blood. 2023 Jan 13:blood.2022017514. doi: 10.1182/blood.2022017514.
    >> Share

  102. RATTIGAN KM, Zarou MM, Helgason V
    Metabolism in stem cell driven leukaemia: parallels between haematopoiesis and immunity.
    Blood. 2023 Jan 12:blood.2022018258. doi: 10.1182/blood.2022018258.
    >> Share

  103. CLARKE ML, Lemma RB, Walton DS, Volpe G, et al
    MYB insufficiency disrupts proteostasis in hematopoietic stem cells leading to age-related neoplasia.
    Blood. 2023 Jan 5:blood.2022019138. doi: 10.1182/blood.2022019138.
    >> Share

    December 2022
  104. CHENG Q, Wang D, Lai X, Liu Y, et al
    The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease.
    Blood. 2022 Dec 27:blood.2022017201. doi: 10.1182/blood.2022017201.
    >> Share


  105. Lehnertz B, Chagraoui J, MacRae T, et al. HLF expression defines the human hematopoietic stem cell state. Blood. 2021;138(25):2642-2654.
    Blood. 2022;140:2761.
    >> Share

  106. GREENBERG ZJ, Monlish D, Chiquetto Paracatu L, Dong Q, et al
    The tetraspanin CD53 protects stressed hematopoietic stem cells via promotion of DREAM complex- mediated quiescence.
    Blood. 2022 Dec 21:blood.2022016929. doi: 10.1182/blood.2022016929.
    >> Share

  107. RAHNAMA R, Bonifant CL
    Engineering builds multipotency for iPSC-NKs.
    Blood. 2022;140:2414-2416.
    >> Share

  108. XIA L
    Engineered platelets for clinical application: a step closer.
    Blood. 2022;140:2314-2315.
    >> Share

  109. SULLIVAN JC, Comenzo R
    Peripheral agglutination and hemolytic anemia following minor ABO-mismatch hematopoietic progenitor cell transplantation.
    Blood. 2022;140:2412.
    >> Share

  110. SUGIMOTO N, Kanda J, Nakamura S, Kitano T, et al
    iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
    Blood. 2022;140:2398-2402.
    >> Share

  111. HSIEH HH, Yao H, Ma Y, Zhang Y, et al
    Epo-IGF1R cross talk expands stress-specific progenitors in regenerative erythropoiesis and myeloproliferative neoplasm.
    Blood. 2022;140:2371-2384.
    >> Share

    November 2022
  112. COOPER JP, Abkowitz JL
    How we diagnose and treat acute graft-versus-host disease after solid organ transplantation.
    Blood. 2022 Nov 17. pii: 493251. doi: 10.1182/blood.2022015954.
    >> Share

  113. MENENDEZ-GUTIERREZ MP, Porcuna J, Nayak RC, Paredes A, et al
    Retinoid X receptor promotes hematopoietic stem cell fitness and quiescence and preserves hematopoietic homeostasis.
    Blood. 2022 Nov 8. pii: 487046. doi: 10.1182/blood.2022016832.
    >> Share

    October 2022
  114. SPERLING AS, Guerra VA, Kennedy JA, Yan Y, et al
    Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
    Blood. 2022;140:1753-1763.
    >> Share

  115. KOYAMA M, Samson L, Ensbey KS, Takahashi S, et al
    Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche.
    Blood. 2022 Oct 6. pii: 486737. doi: 10.1182/blood.2022015808.
    >> Share

  116. LI S, Yao JC, Oetjen KA, Krambs JR, et al
    IL-1beta expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.
    Blood. 2022;140:1607-1620.
    >> Share

    September 2022
  117. CHUTE JP
    Tet2 helps blood cells balance in air.
    Blood. 2022;140:1186-1187.
    >> Share

  118. ZHANG YW, Cabezas-Wallscheid N
    HSCs: slow me down with PLAG1.
    Blood. 2022;140:935-936.
    >> Share

    August 2022
  119. MO F, Watanabe N, Ingersoll Omdahl K, Burkhardt PM, et al
    Engineering T cells to suppress acute GvHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation.
    Blood. 2022 Aug 31. pii: 486464. doi: 10.1182/blood.2022016052.
    >> Share

  120. VAN HALTEREN AGS, Suwandi J, Tuit S, Borst J, et al
    A UNIQUE IMMUNE SIGNATURE IN BLOOD SEPARATES THERAPY-REFRACTORY FROM THERAPY-RESPONSIVE ACUTE GRAFT-VERSUS-HOST DISEASE.
    Blood. 2022 Aug 31. pii: 486465. doi: 10.1182/blood.2022015734.
    >> Share

  121. HULBERT ML, Fields ME, Guilliams KP, Bijlani P, et al
    Normalization of cerebral hemodynamics following hematopoietic stem cell transplant in children with sickle cell disease.
    Blood. 2022 Aug 30. pii: 486449. doi: 10.1182/blood.2022016618.
    >> Share

  122. VALLET N, Le Grand S, Bondeelle L, Hoareau B, et al
    Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
    Blood. 2022 Aug 19. pii: 486351. doi: 10.1182/blood.2022016926.
    >> Share

  123. WANG J, Chang CY, Yang X, Zhou F, et al
    Leukemia inhibitory factor protects against graft-versus-host disease while preserving graft-versus-leukemia activity.
    Blood. 2022 Aug 18. pii: 486317. doi: 10.1182/blood.2022015677.
    >> Share

  124. AN HH, Gagne AL, Maguire JA, Pavani G, et al
    The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine.
    Blood. 2022 Aug 17. pii: 486282. doi: 10.1182/blood.2022015883.
    >> Share

  125. BURGOS DA SILVA M, Ponce DM, Dai A, Devlin SM, et al
    Preservation of fecal microbiome is associated with reduced severity of Graft-versus-Host Disease.
    Blood. 2022 Aug 15. pii: 486225. doi: 10.1182/blood.2021015352.
    >> Share

  126. CHEMINANT M, Fox TA, Alligon M, Bouaziz O, et al
    Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.
    Blood. 2022 Aug 10. pii: 486184. doi: 10.1182/blood.2022015482.
    >> Share

  127. HOLMES ZC, Tang H, Liu C, Bush AT, et al
    Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease.
    Blood. 2022 Aug 5. pii: 486126. doi: 10.1182/blood.2021015178.
    >> Share

  128. MAO X, Li L
    p57Kip2 indirectly regulates AGM HSCs.
    Blood. 2022;140:411-412.
    >> Share

    July 2022
  129. LI C, Wu B, Li Y, Liu Y, et al
    Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitness.
    Blood. 2022 Jul 26. pii: 486023. doi: 10.1182/blood.2022016112.
    >> Share

  130. KULL T, Wehling A, Etzrodt M, Auler M, et al
    NfkappaB signaling dynamics and their target genes differ between mouse blood cell types and induce distinct cell behavior.
    Blood. 2022;140:99-111.
    >> Share

  131. WEHLING A, Loeffler D, Zhang Y, Kull T, et al
    Combined single-cell tracking and omics improves blood stem cell fate regulator identification.
    Blood. 2022 Jul 12. pii: 485878. doi: 10.1182/blood.2022016880.
    >> Share

    June 2022
  132. ALJOUFI A, Zhang C, Ropa J, Chang W, et al
    Physioxia induced Downregulation of Tet2 in Hematopoietic Stem Cells contributes to Enhanced Self-renewal.
    Blood. 2022 Jun 30. pii: 485747. doi: 10.1182/blood.2022015499.
    >> Share

  133. LI J, Williams MJ, Park HJ, Bastos HP, et al
    STAT1 is essential for HSC function and maintains MHCIIhi stem cells that resists myeloablation and neoplastic expansion.
    Blood. 2022 Jun 29. pii: 485724. doi: 10.1182/blood.2021014009.
    >> Share


  134. Liu Y, Chen Q, Jeong H-W, et al. Dopamine signaling regulates hematopoietic stem and progenitor cell function. Blood. 2021;138(21):2051-2065.
    Blood. 2022;139:3668.
    >> Share

  135. LI B, An W, Wang H, Baslan T, et al
    BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.
    Blood. 2022;139:3630-3646.
    >> Share

  136. GALLAGHER PG
    Extramedullary hematopoietic stem cells.
    Blood. 2022;139:3353-3354.
    >> Share

  137. MENDE N, Bastos HP, Santoro A, Mahbubani KT, et al
    Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans.
    Blood. 2022;139:3387-3401.
    >> Share

  138. KAPENI C, Nitsche L, Kilpatrick AM, Wilson NK, et al
    p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion.
    Blood. 2022 Jun 2. pii: 485456. doi: 10.1182/blood.2021014853.
    >> Share


  139. Henden AS, Koyama M, Robb RJ, et al. IFN-lambda therapy prevents severe gastrointestinal graft-versus-host disease. Blood. 2021;138(8):722-737.
    Blood. 2022;139:3346-3351.
    >> Share


  140. Yu Z, Yang W, He X, et al. Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches. Blood. 2022;139(10):1529-1540.
    Blood. 2022;139:3352.
    >> Share

  141. DAVENPORT P, Liu ZJ, Sola-Visner M
    Fetal vs adult megakaryopoiesis.
    Blood. 2022;139:3233-3244.
    >> Share

  142. TILBURG J, Becker IC, Italiano JE
    Don't you forget about me(gakaryocytes).
    Blood. 2022;139:3245-3254.
    >> Share

    May 2022
  143. KEYVANI CHAHI A, Belew MS, Xu J, Chen HTT, et al
    PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal.
    Blood. 2022 May 31. pii: 485426. doi: 10.1182/blood.2021014698.
    >> Share

  144. MENDEZ-FERRER S
    RIG-Ing out BMSCs for hematopoietic recovery after transplantation.
    Blood. 2022;139:3107-3109.
    >> Share

  145. YANG Y, Mumau M, Tober J, Zhu Q, et al
    Endothelial MEKK3-KLF2/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis.
    Blood. 2022;139:2942-2957.
    >> Share

    April 2022
  146. ZHU J, Wang Y, Li JX, Das PK, et al
    Donor Plasmacytoid Dendritic Cells Limit Graft-versus-Host Disease Through Vasoactive Intestinal Polypeptide Expression.
    Blood. 2022 Apr 20. pii: 485002. doi: 10.1182/blood.2021012561.
    >> Share

  147. OVERBEEKE C, Tak T, Koenderman L
    The journey of neutropoiesis: how complex landscapes in bone marrow guide continuous neutrophil lineage determination.
    Blood. 2022;139:2285-2293.
    >> Share

  148. WANG M, Dingler FA, Patel KJ
    Genotoxic aldehydes in the hematopoietic system.
    Blood. 2022;139:2119-2129.
    >> Share

    March 2022

  149. Psatha N, Georgakopoulou A, Li C, et al. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 2021;138(17):1540-1553.
    Blood. 2022;139:2087.
    >> Share

  150. CAZZOLA M
    RNA missplicing and ring sideroblasts in MDS.
    Blood. 2022;139:1933-1935.
    >> Share

  151. ALBERT MH, Sirait T, Eikema DJ, Bakunina K, et al
    Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity, an EBMT IEWP study.
    Blood. 2022 Mar 28. pii: 484506. doi: 10.1182/blood.2022015506.
    >> Share


  152. Cutler C, Lee SJ, Arai S, et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278-2289.
    Blood. 2022;139:1772.
    >> Share

  153. LOU Q, Jiang K, Xu Q, Yuan L, et al
    The RIG-I-NRF2 axis regulates the mesenchymal stromal niche for bone marrow transplantation.
    Blood. 2022 Mar 8. pii: 484313. doi: 10.1182/blood.2021013048.
    >> Share

  154. VERRILLS NM
    PP2A activation targets AML stem cells.
    Blood. 2022;139:1267-1269.
    >> Share

  155. SUO M, Rommelfanger MK, Chen Y, Amro EM, et al
    Age-dependent effects of Igf2bp2 on gene regulation, function, and aging of hematopoietic stem cells in mice.
    Blood. 2022 Mar 1. pii: 484215. doi: 10.1182/blood.2021012197.
    >> Share

    February 2022
  156. LV K, Tong W
    Waking up CML leukemia stem cells for the kill.
    Blood. 2022;139:647-648.
    >> Share

  157. LANDSPERSKY T, Sacma M, Riviere J, Hecker JS, et al
    Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress.
    Blood. 2022;139:690-703.
    >> Share

    January 2022
  158. ALBERT MH, Slatter MA, Gennery AR, Gungor T, et al
    Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis.
    Blood. 2022 Jan 31. pii: 483752. doi: 10.1182/blood.2021014687.
    >> Share

  159. CHIN DWL, Yoshizato T, Virding Culleton S, Grasso F, et al
    Aged healthy mice acquire clonal hematopoiesis mutations.
    Blood. 2022;139:629-634.
    >> Share

  160. STONE AP, Nascimento TF, Barrachina MN
    The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis.
    Blood. 2022;139:483-491.
    >> Share

  161. LAN Y
    Deciphering the continuum of hemogenic endothelium differentiation.
    Blood. 2022;139:308-310.
    >> Share

  162. FADLULLAH MZH, Neo WH, Lie-A-Ling M, Thambyrajah R, et al
    Murine AGM single-cell profiling identifies a continuum of hemogenic endothelium differentiation marked by ACE.
    Blood. 2022;139:343-356.
    >> Share

  163. LOPEZ DE LAPUENTE PORTILLA A, Ekdahl L, Cafaro C, Ali Z, et al
    Genome-wide association study on 13,167 individuals identifies regulators of blood CD34+ cell levels.
    Blood. 2022 Jan 10. pii: 483405. doi: 10.1182/blood.2021013220.
    >> Share

  164. SAHA A, Hyzy S, Lamothe TL, Hammond KJ, et al
    CD45-targeted antibody-drug-conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation.
    Blood. 2022 Jan 5. pii: 483334. doi: 10.1182/blood.2021012366.
    >> Share

    December 2021
  165. CAI H, Kondo M, Sandhow L, Xiao P, et al
    Critical Role of Lama4 for Hematopoiesis Regeneration and Acute Myeloid Leukemia Progression.
    Blood. 2021 Dec 27. pii: 483253. doi: 10.1182/blood.2021011510.
    >> Share

  166. YU Z, Yang W, He X, Chen C, et al
    Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches.
    Blood. 2021 Dec 20. pii: 483187. doi: 10.1182/blood.2021011644.
    >> Share

  167. GANUZA M, Clements WK, McKinney Freeman SL
    Specification of hematopoietic stem cells in mammalian embryos: A rare or frequent event?
    Blood. 2021 Dec 17. pii: 483085. doi: 10.1182/blood.2020009839.
    >> Share

  168. STENGER E
    HSC engraftment in SCD: a MiSCing piece of the puzzle?
    Blood. 2021;138:2451-2452.
    >> Share

  169. MIYAUCHI M, Ito Y, Nakahara F, Hino T, et al
    Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment.
    Blood. 2021;138:2555-2569.
    >> Share

  170. TANG A, Strat AN, Rahman M, Zhang H, et al
    Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease.
    Blood. 2021;138:2570-2582.
    >> Share

  171. CHEN Y, Wang D
    STAT5B, the dominant twin, in hematopoietic stem cells.
    Blood. 2021;138:2303-2305.
    >> Share

  172. QIU Y, Xu M, Huang S
    Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.
    Blood. 2021;138:2327-2336.
    >> Share

  173. WEEKS LD, Marinac CR, Redd RA, Abel GA, et al
    Age-related Diseases of Inflammation in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
    Blood. 2021 Dec 7. pii: 482919. doi: 10.1182/blood.2021014418.
    >> Share

  174. CHEN C, Yu W, Alikarami F, Qiu Q, et al
    Single-cell multiomics reveals increased plasticity, resistant populations and stem-cell-like blasts in KMT2A-rearranged leukemia.
    Blood. 2021 Dec 5. pii: 482898. doi: 10.1182/blood.2021013442.
    >> Share

  175. MOSCA M, Hermange G, Tisserand A, Noble R, et al
    Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNalpha in myeloproliferative neoplasms.
    Blood. 2021;138:2231-2243.
    >> Share

    November 2021
  176. TAMPLIN OJ
    Dopamine motivates stem cells for reward.
    Blood. 2021;138:2012-2014.
    >> Share

  177. LIU Y, Chen Q, Jeong HW, Han D, et al
    Dopamine signaling regulates hematopoietic stem and progenitor cell function.
    Blood. 2021;138:2051-2065.
    >> Share

  178. LADEL L, Jamieson CHM
    Upping the antizyme: AZIN1 directs stem cell fate.
    Blood. 2021;138:1910-1911.
    >> Share

  179. ZHANG H, Wang S, Liu D, Gao C, et al
    EpoR-tdTomato-Cre mice enable identification of EpoR expression in subsets of tissue macrophages and hematopoietic cells.
    Blood. 2021;138:1986-1997.
    >> Share

  180. BRAND M
    Epigenetic plasticity of erythroid progenitors.
    Blood. 2021;138:1646-1648.
    >> Share

  181. FENG Y, Feng W
    Numerous ring sideroblasts in chronic neutrophilic leukemia.
    Blood. 2021;138:1783.
    >> Share

  182. FUCHS EJ, McCurdy SR, Solomon SR, Wang T, et al
    HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
    Blood. 2021 Nov 1. pii: 477735. doi: 10.1182/blood.2021013443.
    >> Share

  183. YANG Y, Kueh AJ, Grant Z, Abeysekera W, et al
    The histone lysine acetyltransferase HBO1 (KAT7) regulates hematopoietic stem cell quiescence and self-renewal.
    Blood. 2021 Nov 1. pii: 477737. doi: 10.1182/blood.2021013954.
    >> Share

    October 2021
  184. SCHNOEDER TM, Schwarzer A, Jayavelu AK, Hsu CJ, et al
    PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
    Blood. 2021 Oct 25. pii: S0006-4971(21)01783-3. doi: 10.1182/blood.2021012778.
    >> Share

  185. DOCAMPO MD, Burgos da Silva M, Lazrak A, Nichols KB, et al
    Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease.
    Blood. 2021 Oct 15. pii: 477329. doi: 10.1182/blood.2021010719.
    >> Share

  186. FISHMAN H, Madiwale S, Geron I, Bari V, et al
    ETV6-NCOA2 fusion induces T/Myeloid mixed-phenotype leukemia by transformation of non-thymic hematopoietic progenitors.
    Blood. 2021 Oct 8. pii: 477216. doi: 10.1182/blood.2020010405.
    >> Share

    September 2021
  187. TERMINI CM, Pang A, Li M, Fang T, et al
    Syndecan-2 expression enriches for hematopoietic stem cells and regulates stem cell repopulating capacity.
    Blood. 2021 Sep 10. pii: 476854. doi: 10.1182/blood.2020010447.
    >> Share

  188. DAVIS AG, Johnson DT, Zheng D, Wang R, et al
    Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia.
    Blood. 2021 Sep 5. pii: 476791. doi: 10.1182/blood.2020005693.
    >> Share

    August 2021
  189. COCHRAN T, Li W
    Frequent internuclear bridging in a Fanconi anemia patient with FANCG mutation.
    Blood. 2021;138:738.
    >> Share

  190. JANN JC, Tothova Z
    Cohesin mutations in myeloid malignancies.
    Blood. 2021;138:649-661.
    >> Share

    July 2021
  191. GURNARI C, Pagliuca S, Durkin L, Terkawi L, et al
    Vacuolization of hematopoietic precursors: an enigma with multiple etiologies.
    Blood. 2021;137:3685-3689.
    >> Share

    June 2021
  192. MIKDAR M, Gonzalez-Menendez P, Cai X, Zhang Y, et al
    The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis.
    Blood. 2021;137:3548-3562.
    >> Share

  193. SOMMERKAMP P, Romero-Mulero MC, Narr A, Ladel L, et al
    Mouse multipotent progenitor 5 cells are located at the interphase between hematopoietic stem and progenitor cells.
    Blood. 2021;137:3218-3224.
    >> Share

  194. PASTORET C, Desmots F, Drillet G, Le Gallou S, et al
    Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
    Blood. 2021;137:3237-3250.
    >> Share

  195. SCHURCH CM, Caraccio C, Nolte MA
    Diversity, localization, and (patho)physiology of mature lymphocyte populations in the bone marrow.
    Blood. 2021;137:3015-3026.
    >> Share

  196. SOMASUNDARAM R, Jensen CT, Tingvall-Gustafsson J, Ahsberg J, et al
    EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Blood. 2021;137:3037-3049.
    >> Share

    May 2021
  197. LIU H
    Basophilic myeloblasts: a clue for CML blast phase.
    Blood. 2021;137:2852.
    >> Share

  198. BORELLA G, Da Ros A, Borile G, Porcu E, et al
    Targeting mesenchymal stromal cells plasticity to reroute acute myeloid leukemia course.
    Blood. 2021 May 19. pii: 475978. doi: 10.1182/blood.2020009845.
    >> Share

  199. TAKEDA MR, Gurbuxani S
    bcr3 PML-RARA: short fusion, small blasts!
    Blood. 2021;137:2708.
    >> Share

  200. SURAPALLY S, Tenen DG, Pulikkan JA
    Emerging therapies for inv(16) AML.
    Blood. 2021;137:2579-2584.
    >> Share

  201. DE RAVIN SS, Brault J, Meis RJ, Liu S, et al
    Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells.
    Blood. 2021;137:2598-2608.
    >> Share

  202. ESTEVEZ B, Borst S, Jarocha D, Sudunagunta V, et al
    RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells.
    Blood. 2021;137:2662-2675.
    >> Share

  203. SILVA AP, Almeida ARM, Cachucho A, Neto JL, et al
    Overexpression of wild type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia/lymphoma.
    Blood. 2021 May 10. pii: 475938. doi: 10.1182/blood.2019000553.
    >> Share

  204. ANAND P, Guillaumet-Adkins A, Dimitrova V, Yun H, et al
    Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.
    Blood. 2021;137:2463-2480.
    >> Share

    March 2021
  205. NIU X, Rothe K, Chen M, Grasedieck S, et al
    Targeting AXL Kinase Sensitizes Leukemic Stem and Progenitor Cells to Venetoclax Treatment in Acute Myeloid Leukemia.
    Blood. 2021 Mar 30. pii: 475648. doi: 10.1182/blood.2020007651.
    >> Share

    January 2021
  206. MU A, Hira A, Niwa A, Osawa M, et al
    Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia-like IBMFS ADH5/ALDH2 deficiency.
    Blood. 2021 Jan 12. pii: 474923. doi: 10.1182/blood.2020009111.
    >> Share

    September 2020
  207. RABOSO-GALLEGO J, Casado-Garcia A, Jiang X, Isidro-Hernandez M, et al
    Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice.
    Blood. 2020 Sep 6. pii: 464123. doi: 10.1182/blood.2020004996.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016